A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers.
Urska JanzicUrska Bidovec-StojkovicPeter KorosecKatja MohorcicLoredana MrakMarina CaksMaja RavnikErik SkofMatija RijavecPublished in: Vaccines (2023)
The third booster vaccination dose against COVID-19 in solid cancer patients triggers substantial immunogenicity and is safe and effective for preventing a severe COVID-19 disease course.